NAD+ supplements have surged in popularity among longevity enthusiasts, but experts remain cautious about their purported anti-aging benefits. According to a new report from National Geographic, while the coenzyme NAD+ plays a crucial role in cellular energy production and DNA repair, the evidence supporting supplementation for extending human lifespan remains limited and preliminary.
NAD+ (nicotinamide adenine dinucleotide) naturally declines with age, prompting supplement companies to market precursors like nicotinamide riboside (NR) and nicotinamide mononucleotide (NMN) as potential fountain-of-youth compounds. These supplements have gained traction in Silicon Valley and among biohackers willing to spend hundreds of dollars monthly on the unproven interventions. The appeal is understandable: animal studies have shown promising results, with some research suggesting NAD+ boosters might improve mitochondrial function and metabolic health in mice.
However, translating those findings to humans has proven challenging. Experts interviewed by National Geographic emphasized that most human studies have been small, short-term, and focused on biomarkers rather than actual longevity outcomes. While some research indicates NAD+ precursors may safely raise NAD+ levels in human cells, whether this translates to meaningful health benefits or extended lifespan remains an open question. The supplements are also expensive and not regulated by the FDA with the same rigor as prescription medications.
The uncertainty hasn’t dampened consumer enthusiasm, with the NAD+ supplement market projected to reach billions in coming years. For consumers considering these products, experts recommend maintaining realistic expectations and prioritizing evidence-based longevity strategies first—including regular exercise, healthy diet, adequate sleep, and stress management. Those interested in NAD+ supplementation should consult healthcare providers, particularly given potential interactions with medications and the lack of long-term safety data. Until more robust clinical trials are completed, NAD+ supplements remain an expensive gamble rather than a proven longevity intervention.
